Skip to main content

News Archive

News Archive - Scott LaFee

Reversing Cancer’s Gluttony

March 18, 2021

Researchers at UC San Diego School of Medicine and Moores Cancer Center describe how pancreatic cancer cells use an alternative method to find necessary nutrients, defying current therapies, to help them grow and spread.

Novel Drug Prevents Amyloid Plaques, a Hallmark of Alzheimer’s Disease

March 2, 2021

Researchers at UC San Diego School of Medicine and elsewhere have identified a new drug that could prevent AD by modulating, rather than inhibiting, a key enzyme involved in forming amyloid plaques.

Repurposed Arthritis Drug Did Not Significantly Improve Severe COVID-19 Pneumonia

March 1, 2021

A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo.

First-in-Human Clinical Trial to Assess Gene Therapy for Alzheimer’s Disease

February 18, 2021

UC San Diego researchers have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer’s disease or Mild Cognitive Impairment, a condition that often precedes full-blown dementia.

Genetics May Play Role in Determining Immunity to COVID-19

February 18, 2021

UC San Diego researchers report that individual immune response to SARS-CoV-2 may be limited by a set of variable genes that code for cell surface proteins essential for the adaptive immune system. The finding may help explain why COVID-19 immunity varies by individual.

New Grant Funds Clinical Trial to Assess Psychedelic as Treatment for Phantom Limb Pain

February 17, 2021

The Psychedelics and Health Research Initiative at UC San Diego has received a $1.3 million grant from the Steven & Alexandra Cohen Foundation to fund a clinical trial investigating the therapeutic potential of psilocybin in treating phantom limb pain.

New Grant Funds Clinical Trial to Assess Psychedelic as Treatment for Phantom Limb Pain

February 17, 2021

The Psychedelics and Health Research Initiative at UC San Diego has received a $1.3 million grant from the Steven & Alexandra Cohen Foundation to fund a clinical trial investigating the therapeutic potential of psilocybin in treating phantom limb pain.

Can Current Smartphone Technology Tell You When a Pandemic Might Come Calling?

February 9, 2021

UC San Diego researchers find that an optical tool already embedded in many smartphones can accurately diagnose blood-oxygen levels and help monitor respiratory disease in patients, particularly when they are quarantined at home.

Poorer Mental Health Smolders After Deadly, Devastating Wildfire

February 9, 2021

UC San Diego researchers report that climate change is a chronic mental health stressor, and promotes a variety of mental health problems. The 2018 Camp Fire is a case study.

Breaking Bad: How Shattered Chromosomes Make Cancer Cells Drug-Resistant

December 23, 2020

UC San Diego and Ludwig Cancer Research scientists describe how a phenomenon known as “chromothripsis” breaks up chromosomes, which then reassemble in ways that ultimately promote cancer cell growth.
Category navigation with Social links